Myocarditis surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(3 intermediate revisions by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
[[Cardiac transplantation]] is sometimes required to treat refractory [[giant cell myocarditis]]. However, the condition can recur in post-transplant patients.<ref name="pmid9197214">{{cite journal| author=Cooper LT, Berry GJ, Shabetai R| title=Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. | journal=N Engl J Med | year= 1997 | volume= 336 | issue= 26 | pages= 1860-6 | pmid=9197214 | doi=10.1056/NEJM199706263362603 | pmc= | url= }} </ref>
[[Cardiac transplantation]] is sometimes required to [[Therapy|treat]] [[refractory]] [[giant cell myocarditis]]. However, the [[condition]] can recur in post-[[transplant]] [[patients]].
==Surgery==
==Surgery==
[[Cardiac transplantation]] is sometimes required to treat refractory [[giant cell myocarditis]]. However, the condition can recur in post-transplant patients.<ref name="pmid9197214">{{cite journal| author=Cooper LT, Berry GJ, Shabetai R| title=Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. | journal=N Engl J Med | year= 1997 | volume= 336 | issue= 26 | pages= 1860-6 | pmid=9197214 | doi=10.1056/NEJM199706263362603 | pmc= | url= }} </ref>
[[Cardiac transplantation]] is sometimes required to [[Therapy|treat]] [[refractory]] [[giant cell myocarditis]]. However, the [[condition]] can recur in post-[[transplant]] [[patients]].<ref name="pmid9197214">{{cite journal| author=Cooper LT, Berry GJ, Shabetai R| title=Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. | journal=N Engl J Med | year= 1997 | volume= 336 | issue= 26 | pages= 1860-6 | pmid=9197214 | doi=10.1056/NEJM199706263362603 | pmc= | url= }} </ref>


==Overview==
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
==Indications==
*Surgical intervention is not recommended for the management of [disease name].
OR
*Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
**[Indication 1]
**[Indication 2]
**[Indication 3]
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
**[Indication 1]
**[Indication 2]
**[Indication 3]
==Surgery==
*The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
*Surgery is the mainstay of treatment for [disease or malignancy].
==Contraindications==


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
 
[[Category:Medicine]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Cardiovascular diseases]]
[[Category:Up-To-Date]]
[[Category:Inflammations]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Intensive care medicine]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]
 
{{WH}}
{{WS}}

Latest revision as of 22:51, 29 July 2020

Myocarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Adrenergic Myocarditis
Giant Cell Myocarditis

Causes

Differentiating Myocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myocarditis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Myocarditis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myocarditis surgery

CDC on Myocarditis surgery

Myocarditis surgery in the news

Blogs on Myocarditis surgery

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myocarditis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant patients.

Surgery

Cardiac transplantation is sometimes required to treat refractory giant cell myocarditis. However, the condition can recur in post-transplant patients.[1]


References

  1. Cooper LT, Berry GJ, Shabetai R (1997). "Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators". N Engl J Med. 336 (26): 1860–6. doi:10.1056/NEJM199706263362603. PMID 9197214.